Markéta Š. M.
- Country
- Czechia
- Department
- Klinický úsek - Ambulance, JIHeP a transplantační jednotka
Research Overview
Data & Insights
Has run more than one trial at 0 of 55 partner sites.
Specializations
Hematologic Disorders
This investigator specializes in the treatment of myelodysplastic syndromes (MDS), with particular emphasis on managing transfusion-dependent anemia in patients with very low to intermediate risk classifications.
- Transfusion-dependent Anemia
- MDS Risk Stratification
- Blood Disorder Management
The research focus includes innovative therapeutic approaches for reducing red blood cell transfusion requirements in MDS patients.
Therapeutic Innovation
The investigator explores novel treatment modalities including elritercept therapy for hematological conditions, specifically targeting transfusion dependency in MDS patients.
- Novel Therapeutic Agents
- Treatment Response Assessment
- Clinical Efficacy Evaluation
Areas of investigation include emerging treatments for improving blood cell production and reducing transfusion requirements.
Supportive Care
The investigator focuses on developing transfusion optimization strategies and supportive care approaches for patients with chronic anemias associated with myelodysplastic syndromes.
- Transfusion Management
- Quality of Life Enhancement
- Long-term Care Strategies
Research interests encompass improving patient outcomes through optimized transfusion protocols and supportive care measures.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.